Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ONCO-ADJUNCT
- Development stage
- Unknown
- Lead developer
- Ultra Botanica
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
ONCO-ADJUNCT is a line of dietary supplements developed by Ultra Botanica specifically for adjunctive use in oncology. The product line, which includes formulations such as ONCO-ADJUNCT Pathway 1, utilizes the proprietary ProtiSorb™ technology—a protein scaffold delivery system designed to significantly enhance the bioavailability of bioactive compounds like curcumin. Curcumin, the primary active ingredient in the flagship formulation, is a polyphenol known to modulate multiple molecular pathways involved in inflammation and cancer, most notably through the inhibition of Nuclear Factor-kappa B (NF-κB) and various pro-inflammatory cytokines. These products are intended to support the health of patients undergoing conventional cancer treatments by providing high-bioavailability nutraceutical support.
- Brand names
- ONCO-ADJUNCT
02
Targets
AMPK (Adenosine monophosphate–activated protein kinase)NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)TNFA (Tumor necrosis factor alpha (soluble))PTGS2 (Prostaglandin-Endoperoxide Synthase 2)SIRT1 (NAD-dependent protein deacetylase sirtuin-1)IL-6 (Interleukin 6)NF-κB
Beyond the preview
Go deeper on ONCO-ADJUNCT.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ONCO-ADJUNCT.